Office of Compliance appoints policy director
Executive Summary
Deborah Autor named CDER Office of Compliance Associate Director for Compliance Policy; she was Department of Justice lead counsel in the case that won FDA its right to collect "disgorgement fees" for GMP violations (1"The Pink Sheet" Oct. 23, 2000, p. 4). In her newly created position, Autor reports to Office of Compliance Acting Director David Horowitz...
You may also be interested in...
CDER Compliance Office Head Horowitz Is Former Associate Chief Counsel
The Center for Drug Evaluation & Research Office of Compliance will be led by a director with experience in litigation and policy development rather than a background in the field offices.
Senators Bring Back Bill Mandating Medicare Payment For Breakthrough Technologies
Four US senators are leading a bipartisan effort to bring potentially life-saving medical treatments to Medicare beneficiaries by requiring reimbursement for breakthrough technologies cleared by the FDA.
HHS/FDA Make It Official: Premarket Notification Required For 7 Types Of Class I Medical Gloves
A joint final order from the US Department of Health and Human Services and the Food and Drug Administration says makers of the low-risk gloves must have 510(k) clearance before sending their products to market.